Introduction
Pneumococcal vaccination is recommended for all adults with asthma and a
Healthy People 2020 goal aims to achieve 60% coverage among high-risk adults,
including those with asthma. Adults with work-related asthma have more severe asthma
symptoms than those with non–work-related asthma and are particularly vulnerable
to pneumococcal pneumonia.
Methods
To assess pneumococcal vaccination coverage by work-related asthma status among
ever-employed adults aged 18–64 years with current asthma, data from the
2012–2013 Behavioral Risk Factor Surveillance System Asthma Call-back Survey for
ever-employed adults (18–64 years) with current asthma from 29 states were
examined in 2016. Adults with work-related asthma had ever been told by a physician
their asthma was work-related. Pneumococcal vaccine recipients self-reported having ever
received a pneumococcal vaccine. Multivariate logistic regression was used to calculate
adjusted prevalence ratios and associated 95% CIs.
Results
Among an estimated 12 million ever-employed adults with current asthma in 29
states, 42.0% received a pneumococcal vaccine. Adults with work-related asthma
were more likely to have received a pneumococcal vaccine than adults with
non–work-related asthma (53.7% versus 35.0%, respectively,
prevalence ratio=1.24, 95% CI=1.06, 1.45). Among adults with
work-related asthma, pneumococcal vaccine coverage was lowest among Hispanics
(36.2%) and those without health insurance (38.5%).
Conclusions
Pneumococcal vaccination coverage among adults with work-related asthma and
non–work-related asthma is below the Healthy People 2020 target level.
Healthcare providers should verify pneumococcal vaccination status in their patients
with asthma and offer the vaccine to those not vaccinated.